Results 1 to 5 of 29
Most popular |Most recent

Trump drug pricing executive orders leave major questions unanswered

USA - August 3 2020 On July 24, 2020, President Trump signed four executive orders relating to drug pricing. These relate to the following four areas: Finalizing the…

Andrew Lu, Kevin M. Madagan, Joseph W. Metro, Sung W. Park, Janine Tougas.

New COVID-19 “CARES Act”: Funding and Flexibilities to Support Health Care System Response to Coronavirus

USA - April 2 2020 President Trump has signed into law the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act or Act),1 sweeping legislation intended to…

Jamie Knauer, Nicole J. Aiken-Shaban, Scot T. Hasselman, John D. Kendzior, Julia Krebs-Markrich, Carol Colborn Loepere, Arielle Lusardi, Kevin M. Madagan, Debra A. McCurdy, Rahul Narula, Sonia Nguyen, Sung W. Park, Ryan M. Pate, Paul W. Pitts, James Segroves.

CMS Rolls Out New Medicare Part D “Senior Savings Model” Designed to Drive Down Insulin Copayments

USA - March 15 2020 The Centers for Medicare and Medicaid Services (CMS) has announced a new voluntary Part D Senior Savings Model (the Model) intended to reduce…

Debra A. McCurdy, Joseph W. Metro.

Changes in California could see significant impact on the price of prescription drugs

USA - June 3 2019 California Governor Gavin Newsom recently signed an Executive Order to allow state agencies to join together and negotiate the purchase of…

Karl E. Herrmann, Joseph W. Metro, Paul W. Pitts, Edward B. Schwartz.

OIG’s Proposed Drug Pricing Safe Harbor Amendments: “Hot Takes”

USA - February 1 2019 Late yesterday, the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released a proposed rule to amend the…

Joseph W. Metro.